glp-1 obesity drug news oct 21 2025 Drugmakers are racing to find the next Wegovy. These trials are ones to watch GLP-1 therapies are changing obesity
Description
2021;372:m4573
Crystal structures of SAMHD1 inhibitor complexes reveal the mechanism of water-mediated dNTP hydrolysis

doi: 10.2337/dbi20-0002
Interestingly, Gabery et al

But if youre really needle-phobic or strongly prefer a daily pill, Rybelsus is absolutely a good choice
